Researchers showed that in C. elegans, the protein MBD-2 regulates genes through repressive histone marks rather than DNA ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.

Explore the complexities of tauopathies and how new research could change their diagnosis and treatment approaches.

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

Recently, the research team led by Professor Jun Pang from the Department of Urology at The Seventh Affiliated Hospital of Sun Yat-sen University ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

Figure 1. Dual binding patterns of MBD proteins in mammals and in C. elegans.In mammals (left), previous studies show that most MBD3 binding sites ...